Brief: ANI Pharmaceuticals Q2 Operating Income USD 12.402 Million
09/08/2023 11:51
Aug 09 (Reuters) - ANI Pharmaceuticals Q2 operating expenses USD 104.145 million. * Q2 revenue USD 116.547 million vs. IBES estimate USD 98.7 million * Q2 net income USD 6.245 million
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma